Abstract
We have shown previously that it is possible to target complement-mediated killing against cultured ovarian tumour cells in vitro. As malignant ovarian cells usually grow in solid nodules in vivo, we have in the present study examined the effectiveness of complement killing against ovarian teratocarcinoma cells (PA-1) growing in three-dimensional tumour microspheroids (TMSs). Our study shows that PA-1 cells growing in TMSs are less susceptible to complement-mediated killing than cells growing in monolayer cultures, even after neutralization of protectin (CD59), the main inhibitor of complement lysis. Cells in suspension and cells growing in TMSs showed a similar expression of membrane co-factor protein (MCP, CD46) and CD59. Decay-accelerating factor (DAF, CD55) was not detected on the surface of cells in suspension, but appeared focally on the outermost cell layers of the TMSs. Complement-activating antibodies bound to all PA-1 cells in suspension but only to the most peripherally located cells in TMSs, even though the target antigens were similarly expressed in the two systems. Antibody-induced complement activation on PA-1 cells in suspension led to C3 and C5b-9 deposition on most cells, while C3 and C5b-9 were only found on the outermost layers of the TMSs. The increased complement resistance of tumour cells growing in three-dimensional spheroids is partly because of an insufficient penetration of antibodies and complement into the TMSs. TMSs are a useful model for the development of more efficient ways to kill malignant cells in micrometastases with monoclonal antibodies and complement.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bjørge, L., Junnikkala, S., Kristoffersen, E. et al. Resistance of ovarian teratocarcinoma cell spheroids to complement-mediated lysis. Br J Cancer 75, 1247–1255 (1997). https://doi.org/10.1038/bjc.1997.213
Issue Date:
DOI: https://doi.org/10.1038/bjc.1997.213
This article is cited by
-
Tumor microenvironment in ovarian cancer peritoneal metastasis
Cancer Cell International (2023)
-
In vitro and in vivo antitumor effects of the VO-chrysin complex on a new three-dimensional osteosarcoma spheroids model and a xenograft tumor in mice
JBIC Journal of Biological Inorganic Chemistry (2016)
-
Three-dimensional and co-culture models for preclinical evaluation of metal-based anticancer drugs
Investigational New Drugs (2015)
-
Ascitic complement system in ovarian cancer
British Journal of Cancer (2005)
-
Secretion of soluble complement inhibitors factor H and factor H-like protein (FHL-1) by ovarian tumour cells
British Journal of Cancer (2002)